Oncology Letters · 2017 · 29 citations · 62 references
MedicineCancer BiologyOncologyCarcinogenesisNeoplasiaTumor ProgressionHuman Papillomavirus InfectionParanasal Sinus CancerSinonasal CancerSinonasal TumorsSquamous Cell CarcinomaImmunological MechanismsInverted PapillomaMalignant Sinonasal TumorsMalignant Transformation RiskOccupational Exposure To Industrial PollutantsSingle-nucleotide PolymorphismsSinonasal Squamous Cell CarcinomaSquamous Papilloma
Sinonasal inverted papilloma (SIP) is a benign tumor of the nasal cavity and sinus. SIP is characterized by aggressive malignant transformation and a high rate of recurrence. Inadequate removal of the tumor during surgery is one of the most significant contributors to SIP recurrence. A growing body of evidence suggests that molecular alteration in SIP, including human papilloma virus infections, single nucleotide polymorphisms of key genes, deregulation of signaling pathways and immunological changes, may lead to SIP occurrence and malignant transformation. However, the extent to which these molecular mechanisms contribute to SIP pathology and transformation remains unclear due to limited research. Further studies are warranted to elucidate the primary dependent factors that contribute to SIP etiology. The present article reviewed risk factors of progression and recurrence of SIP, including outdoor and industrial occupational exposure, smoking, septal deviation, SIP location, recurrent cases, stage of SIP-associated squamous cell carcinoma and choice of surgical method.
62
Johan Vansteenkiste, Sigrid Stroobants, Patrick Dupont et al. · Journal of Clinical Oncology · 1999 · 439 citations
Medicine, Nuclear Medicine, Oncology +17
Development of a Staging System for Inverted Papilloma
John H. Krouse · The Laryngoscope · 2000 · 413 citations · Full text
Medicine, Otolaryngology, Surgery +11
An Evolution in the Management of Sinonasal Inverting Papilloma
Joseph K. Han, Timothy L. Smith, Todd A. Loehrl et al. · The Laryngoscope · 2001 · 177 citations